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Abstract
The synthesis of 3,3-difluoro-2-oxindoles through a robust and efficient palladium-catalyzed C–H 
difluoroalkylation is described. This process generates a broad range of difluorooxindoles from 
readily prepared starting materials. The use of BrettPhos as the ligand was crucial for high 
efficiency. Preliminary mechanistic studies suggest that oxidative addition is the rate-determining 
step for this process.
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The incorporation of fluorinated functional groups into organic molecules has been widely 
recognized as a general strategy in pharmaceutical research and drug development. 
Fluorinated analogues of pharmaceutically relevant compounds often possess properties 
conducive to drug development, such as improved lipophilicity, metabolic stability, and 
bioavailability relative to their nonfluorinated counterparts.[1] For these reasons, substantial 
effort has been devoted to the development of synthetic methods for the assembly of 
fluorinated small molecules.[2] The fluorination[3] and trifluoromethylation[4] of arenes have 
been the most prominent targets of these efforts, and as a result, increasingly general and 
practical methods are now available for these transformations.[2] In contrast, methods for the 
synthesis of difluoroalkylated arenes remain limited.[5] In particular, the synthesis of 
fluorinated heterocyclic compounds by the difluoroalkylation of arenes is a promising but 
underutilized strategy.
Derivatives of oxindole and isatin appear in a variety of naturally occurring and synthetic 
bioactive compounds (Figure 1).[6] As bioisoteric analogs[7] of both classes of heterocycles, 
compounds containing the 3,3-difluoro-2-oxindole ring system have demonstrated 
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considerable promise as potential medicinal agents.[8] There are, however, only a limited 
number of approaches for their preparation, each of which suffers from serious 
drawbacks.[9] Difluorooxindoles have been prepared by the treatment of isatin derivatives 
with diethylaminosulfur trifluoride (DAST) or by electrophilic fluorination of indoles.[9a–c] 
However, the limited stability of the requisite reagents and modest functional group 
tolerance diminish the utility and practicality of these procedures.[10] Moreover, both 
approaches depend on the availability of the pre-existing bicyclic ring system, whose 
construction may be nontrivial. The de novo synthesis of the difluorooxindole ring system 
under free radical conditions[9d] or in the presence of a stoichiometric amount of copper[9e] 
has also been reported. However, these methods are limited by their scope, synthetic 
efficiency, or the accessibility of the required starting materials. A synthesis of 
difluorooxindoles through a palladium-catalyzed C–H difluoroalkylation process[11] would 
constitute a general and practical alternative to these previously reported methods.
In 2003, we disclosed the palladium-catalyzed synthesis of oxindoles from α-
chloroacetanilides.[12] The application of this method to the kilogram-scale synthesis of two 
drug candidates, a serine palmitoyl transferase inhibitor (3)[13] and a long-term 
oxazolidinone antibacterial (4)[14] illustrate the practicality and atom- and step-economical 
advantages of this C–H functionalization protocol. An analogous process wherein 
chlorodifluoroacetanilides are transformed to difluorooxindoles would similarly enable the 
rapid construction of these compounds from readily available starting materials; 
chlorodifluoroacetanilides can be prepared in one step by acylation of the corresponding 
(hetero)arylamines with inexpensive chlorodifluoroacetic anhydride. Although the oxidative 
addition[15] of Pd(0) to the analogous C–Cl bond of chlorodifluoroacetanilides, as well as 
the subsequent C–C bond forming reductive elimination[4a, 16] are expected to be 
challenging processes, we posited that the use of bulky biarylphosphine ligands would 
facilitate these elementary steps. We disclose herein the successful development of an 
efficient palladium-catalyzed C–H difluoroalkylation reaction for the synthesis of 3,3-
difluoro-2-oxindoles.
We began our investigation of the proposed transformation by exposing 
chlorodifluoroacetanilide 1a to base (K2CO3) and palladium catalysts generated from 
premixing[17] 1 mol % of Pd2dba3 and 4 mol % of a variety of phosphine ligands. The use of 
JohnPhos (L1), the optimal ligand for the previous oxindole synthesis, provided 2a in low 
yield (entry 1). Catalysts derived from CyJohnPhos (L2), RuPhos (L3), XPhos (L4) and 
tBuXPhos (L5) were more effective, but still only provided the desired oxindole in low to 
moderate yields (entries 2–5). However, when BrettPhos (L6) was employed as the ligand, 
difluorinated oxindole 2a was isolated in high yield (78%, entry 6). The use of other 
monophosphine ligands, as well as bidentate phosphine ligands, such as PPh3, PCy3, 
P(tBu)3, dppe, BINAP and Xantphos, resulted in low to no conversion to the desired product 
(entries 7–12). No conversion of the starting material was observed in the absence of either 
phosphine ligand or palladium source (entries 13 and 14). Lastly, exposure of 1a to Friedel–
Crafts cyclization conditions (1.2 equiv AlCl3) led to the decomposition of the starting 
material without formation of the desired product.
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Under optimized conditions (Table 2), we explored the substrate scope of this 
transformation. A series of chlorodifluoroacetanilides with electron-rich, -neutral, and -
deficient substituents on the aryl group were found to undergo the desired transformation to 
afford the corresponding difluorooxindoles in good yield. This process was found to be 
compatible with ketone (2h), ester (2g), amide (2i), acetal (2i), hemiaminal (2b), amino (2d, 
2e), and trifluoromethoxy (2f) functional groups.
Given the prevalence of heterocycles in medicinal chemistry, we also investigated the scope 
of heterocyclic substrates.[18] A broad array of heterocycle substrates featuring monocyclic, 
bicyclic, and tricyclic ring were compatible with the optimized reaction conditions. The 
scope included heterocycles such as pyridine (2k), tetrahydroquinoline (2m, 2o), 1,4-
benzoxazine (2n), dihydrophenanthridine (2q), dihydroquinolinone (2p), 
tetrahydrobenzazepine (2r), dihydrodibenzoazepine (2s), tetrahydrobenzooxazepine (2t), 
tetrahydrobenzothioazepine (2x), and tetrahydrobenzodiazepine (2y) ring systems. 
Unsymmetrical indole and carbazole substrates provided products 2j and 2l as 
chromatographically separable regioisomers with moderate selectivity. Interestingly, the 
cyclization occurred preferentially at the more sterically hindered position of these 
substrates, in contrast to our previous palladium-catalyzed oxindole synthesis.[12] To 
demonstrate the robustness of our conditions, the synthesis of 2t was also conducted on a 5 
mmol scale to afford the desired product in undiminished isolated yield.
To probe the mechanism of this transformation, we synthesized isotopically-labeled 
substrates 1a-d1 and 1a-d5 (Scheme 1) for the determination of the intra- and intermolecular 
kinetic isotope effects, respectively. An inverse kinetic isotope effect was observed when 
1a-d1 was subjected to standard reaction conditions (kH/kD = 0.79, eq 1). On the other hand, 
no kinetic isotope effect was observed upon exposure of a 1:1 mixture of 1a and 1a-d5 to the 
standard reaction conditions (kH/kD = 1.01, eq 2).
Based on these data, a plausible mechanism for this transformation is shown in Scheme 2. 
The initial step of this process is likely oxidative addition of the chlorodifluoro amide to 
Pd(0) to generate a Pd(II) enolate. The absence an intermolecular isotope effect indicates 
that the rate-determining step occurs prior to a C–H bond cleavage or rehybridization event, 
suggesting that oxidative addition is rate-determining.[19] Subsequently, electrophilic 
aromatic substitution of the arene furnishes a six-membered palladacycle, which then 
undergoes reductive elimination to provide the observed product and regenerate the Pd(0) 
species. The inverse kinetic isotope effect observed in the intramolecular experiment is 
likely a secondary isotope effect resulting from the sp2 to sp3 rehybridization of the arene 
carbon to which the proton or deuteron is attached.[20] The observation of an inverse isotope 
effect implies that palladation is slow relative to C–H bond cleavage in the electrophilic 
aromatic substitution process, in contrast to our previously reported palladium-catalyzed 
oxindole synthesis from α-chloroacetanilides.[12] Alternative mechanisms in which 
palladation occurs through concerted metalation-deprotonation or σ-bond metathesis 
pathways are excluded on the basis of the observed inverse intramolecular isotope effect.[21]
In summary, we have developed a practical palladium-catalyzed aromatic C–H 
difluoroalkylation reaction using readily available chlorodifluoroacetanilides. The bulky 
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biarylphosphine ligand, BrettPhos, was found to be the only phosphine ligand capable of 
efficiently providing the desired difluorooxindole product. This method allows for the 
straightforward and efficient preparation of a wide range of substituted 3,3-difluoro-2-
oxindoles. The high level of functional group tolerance and ready availability of starting 
materials should make this protocol broadly useful and attractive in academic and industrial 
settings.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Bioactive oxindoles and isatins (top), 3,3-difluoro-2-oxindoles as bioisosteric analogs of 
oxindoles and isatins and their proposed synthesis from chlorodifluoroacetanilides (bottom).
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Scheme 1. 
Observed kinetic isotope effects
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Scheme 2. 
Proposed catalytic cycle (the ligand was omitted for clarity)
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Table 2
Palladium-catalyzed C–H difluoroalkylation of arenes[a].
[a]
Yields of isolated product are an average of two runs on a 1.0 mmol scale.
[b]
Reaction conditions: Pd2dba3 (1 mol%), L6 (4 mol%), 10 h.
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Table 3
Palladium-catalyzed C–H difluoroalkylation of heteroarenes[a].
[a]
Yields of isolated product are an average of two runs in 1.0 mmol scale.
[b]
Reaction was conducted in 5.0 mmol scale.
[c]
r.r.: regioisomeric ratio.
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